126 related articles for article (PubMed ID: 36120242)
21. Role of SOX10 Immunohistochemical Expression in Diagnosing Triple Negative Breast Cancer and Its Correlation With Clinicopathological Features.
Tariq MU; Siddiqui MA; Ud Din N; Kayani N
Cureus; 2024 Apr; 16(4):e59276. PubMed ID: 38813332
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic utility and sensitivities of GATA3 antibodies in triple-negative breast cancer.
Krings G; Nystrom M; Mehdi I; Vohra P; Chen YY
Hum Pathol; 2014 Nov; 45(11):2225-32. PubMed ID: 25150746
[TBL] [Abstract][Full Text] [Related]
23. MCT1 in Invasive Ductal Carcinoma: Monocarboxylate Metabolism and Aggressive Breast Cancer.
Johnson JM; Cotzia P; Fratamico R; Mikkilineni L; Chen J; Colombo D; Mollaee M; Whitaker-Menezes D; Domingo-Vidal M; Lin Z; Zhan T; Tuluc M; Palazzo J; Birbe RC; Martinez-Outschoorn UE
Front Cell Dev Biol; 2017; 5():27. PubMed ID: 28421181
[No Abstract] [Full Text] [Related]
24. Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas.
Karihtala P; Kauppila S; Soini Y; Arja-Jukkola-Vuorinen
BMC Cancer; 2011 Jun; 11():262. PubMed ID: 21693047
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic SOX10 gene signatures in salivary adenoid cystic and breast basal-like carcinomas.
Ivanov SV; Panaccione A; Nonaka D; Prasad ML; Boyd KL; Brown B; Guo Y; Sewell A; Yarbrough WG
Br J Cancer; 2013 Jul; 109(2):444-51. PubMed ID: 23799842
[TBL] [Abstract][Full Text] [Related]
26. Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype.
Wiese DA; Thaiwong T; Yuzbasiyan-Gurkan V; Kiupel M
BMC Cancer; 2013 Sep; 13():403. PubMed ID: 24004841
[TBL] [Abstract][Full Text] [Related]
27. Expression of SIRT1, SIRT3 and SIRT6 Genes for Predicting Survival in Triple-Negative and Hormone Receptor-Positive Subtypes of Breast Cancer.
Uzelac B; Krivokuca A; Brankovic-Magic M; Magic Z; Susnjar S; Milovanovic Z; Supic G
Pathol Oncol Res; 2020 Oct; 26(4):2723-2731. PubMed ID: 32681437
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical Expression Of Matrix Metalloproteinase-1 (MMP-1) in Different Types Of Breast Carcinoma And Its Comparison With ER/PER and HER2/neu.
Shamsi FB; Anwar A; Lail RA; Bukhari MH; Naseem N; Nagi AH
J Ayub Med Coll Abbottabad; 2022; 34(1):12-16. PubMed ID: 35466619
[TBL] [Abstract][Full Text] [Related]
29. Combined SOX10 GATA3 is most sensitive in detecting primary and metastatic breast cancers: a comparative study of breast markers in multiple tumors.
Aphivatanasiri C; Li J; Chan R; Jamidi SK; Tsang JY; Poon IK; Shao Y; Tong J; To KF; Chan SK; Tam F; Cheung SY; Shea KH; Tse GM
Breast Cancer Res Treat; 2020 Nov; 184(1):11-21. PubMed ID: 32737715
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathology Figures and Long-term Effects of Tamoxifen Plus Radiation on Survival of Women with Invasive Ductal Carcinoma and Triple Negative Breast Cancer.
Payandeh M; Sadeghi M; Sadeghi E; Aeinfar M
Asian Pac J Cancer Prev; 2015; 16(12):4863-7. PubMed ID: 26163605
[TBL] [Abstract][Full Text] [Related]
31.
Uzelac B; Krivokuca A; Susnjar S; Milovanovic Z; Supic G
Genet Test Mol Biomarkers; 2021 Mar; 25(3):227-235. PubMed ID: 33734898
[No Abstract] [Full Text] [Related]
32. Cyclooxygenase-2 expression in non-metastatic triple-negative breast cancer patients.
Mosalpuria K; Hall C; Krishnamurthy S; Lodhi A; Hallman DM; Baraniuk MS; Bhattacharyya A; Lucci A
Mol Clin Oncol; 2014 Sep; 2(5):845-850. PubMed ID: 25054056
[TBL] [Abstract][Full Text] [Related]
33. Different prognostic factors correlate with Bcl-2 expression among triple negative and non-triple negative breast cancers.
Abd El-Hafez A; Shawky Mohamed Ael-A; Elesawy BH
Asian Pac J Cancer Prev; 2013; 14(2):1037-41. PubMed ID: 23621182
[TBL] [Abstract][Full Text] [Related]
34. Triple-Negative Breast Cancer in Ghanaian Women: The Korle Bu Teaching Hospital Experience.
Der EM; Gyasi RK; Tettey Y; Edusei L; Bayor MT; Jiagge E; Gyakobo M; Merajver SD; Newman LA
Breast J; 2015; 21(6):627-33. PubMed ID: 26547900
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical Characterization of a Large Cohort of Triple Negative Breast Cancer.
Han R; Nofech-Mozes S; Boles D; Wu H; Curcin N; Slodkowska E
Int J Surg Pathol; 2024 Apr; 32(2):239-251. PubMed ID: 37306115
[No Abstract] [Full Text] [Related]
36. Significantly increased PELP1 protein expression in primary and metastatic triple-negative breast carcinoma: comparison with GATA3 expression and PELP1's potential role in triple-negative breast carcinoma.
Dang DN; Raj G; Sarode V; Molberg KH; Vadlamudi RK; Peng Y
Hum Pathol; 2015 Dec; 46(12):1829-35. PubMed ID: 26428280
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological factors associated with novel prognostic markers for patients with triple negative breast cancer.
Badowska-Kozakiewicz AM; Budzik MP; Liszcz A; Sobieraj MT; Czerw AI; Sobol M; Patera J; Deptała A
Arch Med Sci; 2019 Oct; 15(6):1433-1442. PubMed ID: 31749871
[TBL] [Abstract][Full Text] [Related]
38. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
Tsutsumi Y
Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
[TBL] [Abstract][Full Text] [Related]
39. SOX10 induced Nestin expression regulates cancer stem cell properties of TNBC cells.
Feng W; Liu S; Zhu R; Li B; Zhu Z; Yang J; Song C
Biochem Biophys Res Commun; 2017 Apr; 485(2):522-528. PubMed ID: 28189679
[TBL] [Abstract][Full Text] [Related]
40. PKCλ/ι signaling promotes triple-negative breast cancer growth and metastasis.
Paul A; Gunewardena S; Stecklein SR; Saha B; Parelkar N; Danley M; Rajendran G; Home P; Ray S; Jokar I; Vielhauer GA; Jensen RA; Tawfik O; Paul S
Cell Death Differ; 2014 Sep; 21(9):1469-81. PubMed ID: 24786829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
